| Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV TP Sheahan, AC Sims, SR Leist, A Schäfer, J Won, AJ Brown, ... Nature communications 11 (1), 222, 2020 | 2131 | 2020 |
| Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses TP Sheahan, AC Sims, RL Graham, VD Menachery, LE Gralinski, ... Science translational medicine 9 (396), eaal3653, 2017 | 1926 | 2017 |
| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness KS Corbett, DK Edwards, SR Leist, OM Abiona, S Boyoglu-Barnum, ... Nature 586 (7830), 567-571, 2020 | 1628 | 2020 |
| SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract YJ Hou, K Okuda, CE Edwards, DR Martinez, T Asakura, KH Dinnon, ... Cell 182 (2), 429-446. e14, 2020 | 1614 | 2020 |
| An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice TP Sheahan, AC Sims, S Zhou, RL Graham, AJ Pruijssers, ML Agostini, ... Science translational medicine 12 (541), eabb5883, 2020 | 1148 | 2020 |
| SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo YJ Hou, S Chiba, P Halfmann, C Ehre, M Kuroda, KH Dinnon III, SR Leist, ... Science 370 (6523), 1464-1468, 2020 | 977 | 2020 |
| A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures KH Dinnon III, SR Leist, A Schäfer, CE Edwards, DR Martinez, ... Nature 586 (7830), 560-566, 2020 | 730 | 2020 |
| Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis LE Gralinski, TP Sheahan, TE Morrison, VD Menachery, K Jensen, ... MBio 9 (5), 10.1128/mbio. 01753-18, 2018 | 615 | 2018 |
| A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice SR Leist, KH Dinnon, A Schäfer, VT Longping, K Okuda, YJ Hou, A West, ... Cell 183 (4), 1070-1085. e12, 2020 | 596 | 2020 |
| Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice AJ Pruijssers, AS George, A Schäfer, SR Leist, LE Gralinksi, KH Dinnon, ... Cell reports 32 (3), 2020 | 526 | 2020 |
| Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2 AC Walls, B Fiala, A Schäfer, S Wrenn, MN Pham, M Murphy, ... Cell 183 (5), 1367-1382. e17, 2020 | 520 | 2020 |
| SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 A Wahl, LE Gralinski, CE Johnson, W Yao, M Kovarova, KH Dinnon III, ... Nature 591 (7850), 451-457, 2021 | 413 | 2021 |
| Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ... Journal of Experimental Medicine 218 (3), e20201993, 2020 | 342 | 2020 |
| Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice DR Martinez, A Schäfer, SR Leist, G De la Cruz, A West, ... Science 373 (6558), 991-998, 2021 | 185 | 2021 |
| Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines AC Walls, MC Miranda, A Schäfer, MN Pham, A Greaney, ... Cell 184 (21), 5432-5447. e16, 2021 | 169 | 2021 |
| Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020; 11 (1): 222 TP Sheahan, AC Sims, SR Leist, A Schäfer, J Won, AJ Brown, ... Lancet 395, 1569-78, 2020 | 166 | 2020 |
| Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection CE Edwards, BL Yount, RL Graham, SR Leist, YJ Hou, KH Dinnon III, ... Proceedings of the National Academy of Sciences 117 (43), 26915-26925, 2020 | 139 | 2020 |
| High potency of a bivalent human VH domain in SARS-CoV-2 animal models W Li, A Schäfer, SS Kulkarni, X Liu, DR Martinez, C Chen, Z Sun, SR Leist, ... Cell 183 (2), 429-441. e16, 2020 | 128 | 2020 |
| Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate W Sun, SR Leist, S McCroskery, Y Liu, S Slamanig, J Oliva, F Amanat, ... EBioMedicine 62, 2020 | 114 | 2020 |
| COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge AT DiPiazza, SR Leist, OM Abiona, JI Moliva, A Werner, M Minai, ... Immunity 54 (8), 1869-1882. e6, 2021 | 94 | 2021 |
